Cardiology Stents - DES

Description

The Common Services Agency (more commonly known as National Services Scotland) (‘the Authority’) acting through its division Procurement, Commissioning & Facilities is undertaking this procurement of the supply and delivery of Cardiology Stents for use in Percutaneous Coronary Intervention procedures (Angioplasty) and related service and support (‘Products’) on behalf of all entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. all NHS Scotland Health Boards, Special Health Boards and the Authority or other NHS Organisation established pursuant to the NHS (Scotland) Act 1978), any integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014 (collectively hereafter referred to as ‘Participating Authorities’) Lot 1: Workhorse Drug Eluting Stents Provision of Workhorse Drug Eluting Stents for use in Cardiology. We envisage that a maximum of four (4) potential Framework Participants who scored the highest score for each lot (assessed against the award criteria) will be appointed to the Framework Agreement. Lot 2: High Risk Bleed Drug Eluting Stents Provision of High Risk Bleed Drug Eluting Stents for use in Cardiology. We envisage that a maximum of four (4) potential Framework Participants who scored the highest score for each lot (assessed against the award criteria) will be appointed to the Framework Agreement. Lot 3: Niche Product Drug Eluting Stents Provision of Niche Product Drug Eluting Stents for use in Cardiology. We envisage that a maximum of four (4) potential Framework Participants who scored the highest score for each lot (assessed against the award criteria) will be appointed to the Framework Agreement.